SL

Shifeng Liu

HC Hangzhou Innogate Pharma Co.: 2 patents #2 of 3Top 70%
Overall (2022): #111,593 of 548,613Top 25%
2
Patents 2022

Issued Patents 2022

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDate
11352353 Heterocyclic compound serving as FGFR4 inhibitor Hancheng ZHANG, Xiangyang YE 2022-06-07
11225492 Heterocycles useful as anti-cancer agents Hancheng ZHANG 2022-01-18